Posted in M&A / Deals Alzheimer’s biotech Korsana to go public via reverse merger April 2, 2026 Pharmaphorum By merging with Cyclerion, Korsana will get a Nasdaq listing and additional cash to develop its new-generation amyloid-targeting drug for Alzheimer’s. M&A / DealsNeuroscienceRead full story